Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer

The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.

Trial Details

NCT ID
NCT06252233
Phase
NA
Sponsor
University of Bayreuth
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • patient- and physician-centered QoL monitoring
  • Placebo
Locations (sample)
  • Bamberg, Germany|49.89873,10.90067
  • Bayreuth, Germany|49.94782,11.57893
  • Coburg, Germany|50.25937,10.96384
  • Donaustauf, Germany|49.03258,12.20459
  • Kulmbach, Germany|50.10068,11.45032

Key Eligibility Criteria

  • primary diagnosis of lung cancer (ICD C33/C34, all stages)
  • treatment in one of six recruiting hospitals treating patients with lung cancer (University Hospital Regensburg, Hospital Barmherzige Brüder Regens…
  • difference between date of histology and date of study entry not exceeding 2 months;
  • informed consent;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →